Publication: Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis
| dc.contributor.author | Lax Pérez, Antonio Manuel | |
| dc.contributor.author | Fernandez del Palacio, Maria Josefa | |
| dc.contributor.author | Pascual Oliver, Silvia | |
| dc.contributor.author | Ruiz Ballester, Miriam | |
| dc.contributor.author | Fuster, Jose J | |
| dc.contributor.author | Pascual Figal, Domingo A. | |
| dc.contributor.author | Asensio Lopez, Maria del Carmen | |
| dc.contributor.author | Soler Pardo, Fernando | |
| dc.contributor.department | Medicina | |
| dc.date.accessioned | 2024-01-23T08:54:00Z | |
| dc.date.available | 2024-01-23T08:54:00Z | |
| dc.date.issued | 2023-05 | |
| dc.description | ©2023. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This document is the Accepted version of a Published Work that appeared in final form in Molecular Therapy - Nucleic Acids. To access the final edited and published work see https://doi.org/10.1016/j.omtn.2023.04.031 | es |
| dc.format | application/pdf | es |
| dc.format.extent | 17 | es |
| dc.identifier.citation | Mol Ther Nucleic Acids. 2023 May 3:32:704-720. doi: 10.1016/j.omtn.2023.04.031. eCollection 2023 Jun 13. | |
| dc.identifier.doi | 10.1016/j.omtn.2023.04.031. | |
| dc.identifier.issn | 2162-2531 | |
| dc.identifier.uri | http://hdl.handle.net/10201/137581 | |
| dc.language | eng | es |
| dc.relation | This study was supported by a grant from the Instituto de Salud Carlos III (PI19/00519). A.L. is a Ramon and Cajal Researcher in the Department of Medicine, University of Murcia (RYC2019-027635-I; supported by MCIN/AEI/10.13039/501100011033 and by FSE for the future) | es |
| dc.rights | info:eu-repo/semantics/openAccess | es |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.title | Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis | es |
| dc.type | info:eu-repo/semantics/article | es |
| dspace.entity.type | Publication | es |
| relation.isAuthorOfPublication | fb419085-b327-4302-860b-d0f7e5000ea9 | |
| relation.isAuthorOfPublication.latestForDiscovery | fb419085-b327-4302-860b-d0f7e5000ea9 |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55aYY1sST2 signaling axis.pdf
- Size:
- 3.36 MB
- Format:
- Adobe Portable Document Format
- Description:
Loading...
- Name:
- Datos suplementarios.pdf
- Size:
- 4.92 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.26 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
Collections
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/